Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Veterinary Medicine

PUBLISHER: Grand View Research | PRODUCT CODE: 1611182

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1611182

U.S. Animal Health Market Size, Share & Trends Analysis Report By Animal Type (Production Animal, Companion Animal), By Product, By Type Of Vaccine, By Disease, By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

U.S. Animal Health Market Growth & Trends:

The U.S. animal health market size is expected to reach USD 19.77 billion by 2030, registering a CAGR of 7.97% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by growing animal population and ownership rates, increased expenditure on animals, an increasing focus on preventative animal healthcare, advances in veterinary medicine, and rising R&D investment in veterinary pharmaceuticals to launch innovative products. For instance, in November 2024, Bimeda launched MoxiSolv Injection (moxidectin), an FDA-approved parasiticide for beef and non-lactating dairy cattle, in a convenient, non-shattering 500 mL plastic bottle.

Furthermore, the industry is also driven by rising incidences of zoonotic diseases, increased livestock population, growing focus on preventive care, and growing animal expenditure. The livestock population in the U.S. has increased, with significant growth in cattle, sheep, pigs, and poultry being raised for meat production. For instance, as of January 2024, the U.S. had 87.8 million cattle and 74.97 million swine stock, according to the U.S. Foreign Agricultural Service's Livestock and Poultry: World Markets and Trade report. This substantial livestock population necessitates comprehensive veterinary care and medical interventions to maintain health and productivity.

In addition, the economic significance of the cattle industry, which contributes over USD 70 billion annually, has driven stakeholders to prioritize health management to mitigate potential losses due to diseases. The rising consumer demand for high-quality beef and dairy products and growing awareness of sustainable farming practices have also played a crucial role in adopting health management solutions for cattle. Government-backed initiatives and enhanced veterinary services in rural areas further strengthen the sector, ensuring its continued expansion.

Additionally, increasing approval of medicated feed additives significantly drives the market by improving livestock health and production efficiency. For instance, in June 2024, The FDA approved Elanco's methane-reducing feed additive, Bovaer (3-NOP), for lactating dairy cattle. Bovaer can reduce methane emissions by 30% per cow, potentially lowering emissions equivalent to removing 285,000 cars from the road annually if used by one million cows. This innovation offers financial incentives for dairy farmers through carbon markets, supporting sustainability efforts and meeting global climate goals. In partnership with dsm-Firmenich, Elanco will market Bovaer across North America, contributing to sustainable farming practices and enhancing the dairy industry's competitiveness.

Similarly, rapid advancements in veterinary medicine present lucrative opportunities in the industry. Improvements in animal pharmaceuticals result in the development of more focused and efficient therapies for many kinds of animal illnesses and ailments. Furthermore, the demand for innovative veterinary medications is being driven by new drugs and therapies that provide better results for animals, decreased side effects, and increased efficacy. For instance, in September 2024, Merck Animal Health expanded its NOBIVAC NXT vaccine platform by launching NOBIVAC NXT FeLV, the first RNA vaccine for feline leukemia virus (FeLV). This innovative vaccine offers optimized protection against FeLV, a common feline infectious disease, and is expected to be available at veterinary clinics nationwide. Similarly, in June 2024, Bimeda launched Bimasone, the first FDA-approved generic flumethasone, used to treat inflammation and allergic conditions in horses, dogs, and cats.

U.S. Animal Health Market Report Highlights:

  • Based on product, the pharmaceuticals segment accounted for the highest revenue share in 2024. However, the biologics segment is anticipated to grow at the fastest CAGR over the forecast period.
  • Based on animals, the production animal segment held the largest share in 2024 owing to rising incidences of zoonotic diseases, increased livestock population, growing focus on preventive care, and increased animal expenditure.
  • Based on the type of vaccine, the cattle vaccine segment dominated the market in 2024, and it is expected to grow fastest with a CAGR of 9.52% over the forecast period.
  • Based on the route of administration, the oral segment dominated the market with a share in 2024. This growth can be attributed to new product launches such as chewable tablets by the industry players. However, the topical segment is anticipated to grow at the fastest CAGR of 9.13% over the forecast period.
Show more
Product Code: GVR-4-68040-492-5

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Scope
    • 1.1.2. Estimates And Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis
    • 1.6.2. Global Market: CAGR Calculation
  • 1.7. Research Scope and Assumptions
    • 1.7.1. List of Secondary Sources
    • 1.7.2. List of Primary Sources
    • 1.7.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Animal Health Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising Prevalence of Animal Diseases
      • 3.2.1.2. Growing Uptake Of Pet Insurance
      • 3.2.1.3. Increase In Pet Population & Pet Humanization
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High cost of treatment
      • 3.2.2.2. Adverse effects associated with therapies
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. U.S. Animal Health Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal landscape
  • 3.4. Covid-19 Analysis
  • 3.5. Estimated Pet Population by key countries

Chapter 4. U.S. Animal Health Market: Animal Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Animal Health Market Movement Analysis
  • 4.3. U.S. Animal Health Market Size & Trend Analysis, by Animal, 2018 to 2030 (USD Million)
    • 4.3.1. Production Animals
      • 4.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.2. Poultry
        • 4.3.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.3. Swine
        • 4.3.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.4. Cattles
        • 4.3.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.5. Sheep & Goats
        • 4.3.1.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.6. Fish
        • 4.3.1.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Companion Animals
      • 4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.2. Dogs
        • 4.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.3. Cats
        • 4.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.4. Horses
        • 4.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.5. Others
        • 4.3.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Animal Health Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Animal Health Market Movement Analysis
  • 5.3. U.S. Animal Health Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
    • 5.3.1. Biologics
      • 5.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.1.2. Vaccines
        • 5.3.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.1.2.2. Attenuated Live Vaccines
          • 5.3.1.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.1.2.3. Inactivated Vaccines
          • 5.3.1.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.1.2.4. Subunit Vaccines
          • 5.3.1.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.1.2.5. DNA Vaccines
          • 5.3.1.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
          • 5.3.1.2.5.2. Recombinant Vaccines
          • 5.3.1.2.5.3. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
          • 5.3.1.2.5.4. Autogenous Vaccines
          • 5.3.1.2.5.5. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
          • 5.3.1.2.5.6. Other Biologics
          • 5.3.1.2.5.7. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Pharmaceuticals
      • 5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.2. Parasiticides
        • 5.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.3. Anti-infectives
        • 5.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.4. Anti-inflammatory
        • 5.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.5. Analgesics
        • 5.3.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.6. Other Pharmaceuticals
        • 5.3.2.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Medicinal Feed Additives
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Animal Health Market: Type of Vaccine Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Animal Health Market Movement Analysis
  • 6.3. U.S. Animal Health Market Size & Trend Analysis, by Type of Vaccine, 2018 to 2030 (USD Million)
    • 6.3.1. Cattle Vaccine
      • 6.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Porcine Vaccine
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Poultry Vaccine
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Aquaculture Vaccine
      • 6.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Other Vaccines
      • 6.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Animal Health Market: Disease Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Animal Health Market Movement Analysis
  • 7.3. U.S. Animal Health Market Size & Trend Analysis, by Disease, 2018 to 2030 (USD Million)
    • 7.3.1. Cattle Disease
      • 7.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. Porcine Disease
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Poultry Disease
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Aquaculture Disease
      • 7.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Other Disease
      • 7.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. U.S. Animal Health Market: Route of Administration Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Animal Health Market Movement Analysis
  • 8.3. U.S. Animal Health Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
    • 8.3.1. Oral
      • 8.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. Injectable
      • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.3.2.2. Subcutaneous
        • 8.3.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.3.2.3. Intramuscular
        • 8.3.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.3.2.4. Intravenous
        • 8.3.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Topical
      • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Other
      • 8.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. U.S. Animal Health Market: Distribution Channel Estimates & Trend Analysis

  • 9.1. Segment Dashboard
  • 9.2. U.S. Animal Health Market Movement Analysis
  • 9.3. U.S. Animal Health Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
    • 9.3.1. Retail
      • 9.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. E-Commerce
      • 9.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Hospital/ Clinic Pharmacy
      • 9.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Company Market Position Analysis/ Heat Map Analysis
  • 10.3. Strategy Mapping
    • 10.3.1. Mergers & Acquisitions
    • 10.3.2. Partnerships & Collaborations
    • 10.3.3. Others
  • 10.4. Company Profiles
    • 10.4.1. Zoetis Inc.
      • 10.4.1.1. Participant's Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Ceva Sante Animale
      • 10.4.2.1. Participant's Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Merck & Co., Inc.
      • 10.4.3.1. Participant's Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. Vetoquinol S.A.
      • 10.4.4.1. Participant's Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. Boehringer Ingelheim Gmbh
      • 10.4.5.1. Participant's Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Elanco Animal Health Incorporated
      • 10.4.6.1. Participant's Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Virbac
      • 10.4.7.1. Participant's Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. Phibro Animal Health Corporation
      • 10.4.8.1. Participant's Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Dechra Pharmaceuticals Plc
      • 10.4.9.1. Participant's Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. Bimeda, Inc.
      • 10.4.10.1. Participant's Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives
    • 10.4.11. Cargill, Incorporated.
      • 10.4.11.1. Participant's Overview
      • 10.4.11.2. Financial Performance
      • 10.4.11.3. Product Benchmarking
      • 10.4.11.4. Strategic Initiatives
    • 10.4.12. Aurora Pharmaceutical, Inc.
      • 10.4.12.1. Participant's Overview
      • 10.4.12.2. Financial Performance
      • 10.4.12.3. Product Benchmarking
      • 10.4.12.4. Strategic Initiatives
    • 10.4.13. Calier
      • 10.4.13.1. Participant's Overview
      • 10.4.13.2. Financial Performance
      • 10.4.13.3. Product Benchmarking
      • 10.4.13.4. Strategic Initiatives

Chapter 11. Key Takeaways

Show more
Product Code: GVR-4-68040-492-5

List of Tables

  • Table 1 Cost of surgeries, USD
  • Table 2 Pricing analysis for vaccines (USD), 2024
  • Table 3 Estimated animal population in U.S. by key species, 2018 to 2023
  • Table 4 U.S. Animal Health Market Revenue Estimates and Forecast, By Product, 2018 - 2030 (USD Million)
  • Table 5 U.S. Animal Health Market Revenue Estimates and Forecast, By Biologics, 2018 - 2030 (USD Million)
  • Table 6 U.S. Animal Health Market Revenue Estimates and Forecast, By Vaccines, 2018 - 2030 (USD Million)
  • Table 7 U.S. Animal Health Market Revenue Estimates and Forecast, By Pharmaceuticals, 2018 - 2030 (USD Million)
  • Table 8 U.S. Animal Health Market Revenue Estimates and Forecast, By Animal Type, 2018-2030 (USD million)
  • Table 9 U.S. Animal Health Market Revenue Estimates and Forecast, By Production Animal, 2018 - 2030 (USD Million)
  • Table 10 U.S. Animal Health Market Revenue Estimates and Forecast, By Companion Animal, 2018 - 2030 (USD Million)
  • Table 11 U.S. Animal Health Market Revenue Estimates and Forecast, By Type of Vaccine, 2018 - 2030 (USD Million)
  • Table 12 U.S. Animal Health Market Revenue Estimates and Forecast, By Disease, 2018 - 2030 (USD Million)
  • Table 13 U.S. animal health market estimates and forecast, by Route of administration, 2018 - 2030 (USD Million)
  • Table 14 U.S. Animal Health Market Revenue Estimates and Forecast, By Injectables, 2018 - 2030 (USD Million)
  • Table 15 U.S. Animal Health Market Revenue Estimates and Forecast, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Participants' overview
  • Table 17 Financial performance
  • Table 18 Products benchmarking
  • Table 19 Estimated Company Market Share in U.S Animal Health Market
  • Table 20 Estimated Company Market Share in U.S Animal Health Pharmaceutical Market
  • Table 21 Estimated Company Market Share in U.S Animal Health Vaccines Market
  • Table 22 Estimated Company Market Share in the U.S Animal Health Medicated Feed Additives Market
  • Table 23 Key market players initiating expansion
  • Table 24 Key market players initiating mergers & acquisitions
  • Table 25 Key market players initiating partnerships & collaborations.
  • Table 26 Key market players initiating service launches/expansions
  • Table 27 Key market players undertaking approvals
  • Table 28 Key market players undertaking other activities
  • Table 29 List of key market players

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 General methodology for Commodity flow analysis of Animal Health market
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Segment-level bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market analysis, 2024 (USD billion)
  • Fig. 17 Ancillary market outlook, 2024
  • Fig. 18 U.S. animal health market dynamics
  • Fig. 19 Estimated number of U.S. households owning a pet (2024)
  • Fig. 20 U.S. animal health market: PORTER's analysis
  • Fig. 21 U.S. animal health market: PESTEL analysis
  • Fig. 22 U.S. Animal Health market by product type: Key takeaways
  • Fig. 23 U.S. Animal Health market by product type market share, 2024 & 2030
  • Fig. 24 Biologics market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Attenuated vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Inactivated vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Subunit vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 DNA vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Recombinant vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Autogenous vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Other biologics market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Pharmaceuticals market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Parasiticides market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Anti-infectives market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Anti-inflammatory market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Analgesics market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Other market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Medicinal feed additives market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. animal health market by animal type: Key takeaways
  • Fig. 41 U.S. animal health market by animal type market share, 2023 & 2030
  • Fig. 42 Production animal market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Swine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Poultry market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Cattle market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Sheep & goats market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Fish market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Companion animal market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Dogs market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Cats market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Horses market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Other market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 U.S. animal health market by type of vaccine: Key takeaways
  • Fig. 54 U.S. animal health market by type of vaccine market share, 2024 & 2030
  • Fig. 55 Cattle vaccine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Porcine vaccine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Poultry vaccine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Aquaculture vaccine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Other vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 U.S. animal health market by Disease: Key takeaways
  • Fig. 61 U.S. animal health market by disease market share, 2024 & 2030
  • Fig. 62 Porcine disease market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Poultry diseases market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Cattle diseases market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Aquaculture diseases market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Other diseases market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 U.S. animal health market by Route of administration: Key takeaways
  • Fig. 68 U.S. animal health market by Route of administration, market share, 2024 & 2030
  • Fig. 69 Oral market, 2018 - 2030 (USD Million)
  • Fig. 70 Injectable market, 2018 - 2030 (USD Million)
  • Fig. 71 Subcutaneous market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Intramuscular market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Intravenous market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Topical market, 2018 - 2030 (USD Million)
  • Fig. 75 Other market, 2018 - 2030 (USD Million)
  • Fig. 76 U.S. animal health market by distribution channel: Key takeaways
  • Fig. 77 U.S. Animal Health market by distribution channel market share, 2024 & 2030
  • Fig. 78 Retail market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 E-Commerce market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Hospital/Clinic Pharmacy market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Market participant categorization
  • Fig. 82 Heat map analysis
  • Fig. 83 Key strategies deployed by market players
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!